Topical 5% Imiquimod Long-Term Treatment of Cutaneous Warts Resistant to Standard Therapy Modalities

Publisher： Karger

E-ISSN： 1421-9832|205|2|139-145

ISSN： 1018-8665

Source： Dermatology, Vol.205, Iss.2, 2002-08, pp. : 139-145

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Imiquimod, a Topical Immune Response Modifier, in the Treatment of Cutaneous Metastases of Malignant Melanoma

By  

Dermatology, Vol. 205, Iss. 2, 2002-08 ,pp. : 135-138

Karger

Access to resources Recommend Favorite

Topical Treatment of Lentigo maligna Melanoma with Imiquimod 5% Cream

By  

Dermatology, Vol. 207, Iss. 3, 2003-10 ,pp. : 326-328

Karger

Access to resources Recommend Favorite

Topical Imiquimod Treatment of Lentigo Maligna

By  

Case Reports in Dermatology, Vol. 1, Iss. 1, 2009-10 ,pp. : 78-81

Karger

Access to resources Recommend Favorite

Successful Treatment of Cutaneous Botryomycosis with a Combination of Minocycline and Topical Heat Therapy

By  

Case Reports in Dermatology, Vol. 4, Iss. 2, 2012-05 ,pp. : 114-118

Karger

Access to resources Recommend Favorite

5% Topical Imiquimod Tolerance in Transplant Recipients

By  

Dermatology, Vol. 215, Iss. 2, 2007-08 ,pp. : 130-133

Karger

Access to resources Recommend Favorite